Filomena de Nigris

7.5k total citations
111 papers, 5.7k citations indexed

About

Filomena de Nigris is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Filomena de Nigris has authored 111 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 26 papers in Immunology and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Filomena de Nigris's work include Atherosclerosis and Cardiovascular Diseases (18 papers), Antioxidant Activity and Oxidative Stress (12 papers) and Angiogenesis and VEGF in Cancer (9 papers). Filomena de Nigris is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (18 papers), Antioxidant Activity and Oxidative Stress (12 papers) and Angiogenesis and VEGF in Cancer (9 papers). Filomena de Nigris collaborates with scholars based in Italy, United States and United Kingdom. Filomena de Nigris's co-authors include Claudio Napoli, Louis J. Ignarro, Wulf Palinski, Sharon Williams‐Ignarro, Vincenzo Sica, Lilach O. Lerman, Francesco Paolo D’Armiento, Orlando Pignalosa, M Condorelli and Concetta Schiano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Filomena de Nigris

109 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Filomena de Nigris Italy 46 2.2k 914 900 827 824 111 5.7k
Timothy E. Peterson United States 35 2.4k 1.1× 1.4k 1.5× 2.0k 2.3× 876 1.1× 554 0.7× 68 6.2k
Renee Leboeuf United States 49 2.4k 1.1× 662 0.7× 1.3k 1.5× 1.2k 1.5× 622 0.8× 107 6.5k
Lawrence W. Castellani United States 41 2.2k 1.0× 788 0.9× 766 0.9× 804 1.0× 541 0.7× 71 6.6k
Toshiaki Tamaki Japan 41 1.8k 0.8× 1.0k 1.1× 1.2k 1.3× 533 0.6× 392 0.5× 201 5.1k
Hunjoo Ha South Korea 49 2.8k 1.2× 441 0.5× 1.1k 1.2× 729 0.9× 512 0.6× 167 7.8k
Nichola Figg United Kingdom 36 2.6k 1.2× 628 0.7× 727 0.8× 1.5k 1.9× 643 0.8× 67 5.6k
Wolfgang Siess Germany 49 3.1k 1.4× 1.8k 2.0× 958 1.1× 934 1.1× 360 0.4× 157 8.0k
Colin H. Macphee United States 41 2.6k 1.2× 851 0.9× 970 1.1× 1.2k 1.5× 1.4k 1.7× 90 7.1k
Gadiparthi N. Rao United States 41 3.0k 1.3× 416 0.5× 622 0.7× 897 1.1× 711 0.9× 130 5.2k
Eugene A. Podrez United States 34 2.7k 1.2× 698 0.8× 887 1.0× 2.8k 3.4× 597 0.7× 76 6.9k

Countries citing papers authored by Filomena de Nigris

Since Specialization
Citations

This map shows the geographic impact of Filomena de Nigris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filomena de Nigris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filomena de Nigris more than expected).

Fields of papers citing papers by Filomena de Nigris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filomena de Nigris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filomena de Nigris. The network helps show where Filomena de Nigris may publish in the future.

Co-authorship network of co-authors of Filomena de Nigris

This figure shows the co-authorship network connecting the top 25 collaborators of Filomena de Nigris. A scholar is included among the top collaborators of Filomena de Nigris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filomena de Nigris. Filomena de Nigris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bua, Silvia, Alessio Nocentini, Alessandro Bonardi, et al.. (2024). Harnessing Nitric Oxide-Donating Benzofuroxans for Targeted Inhibition of Carbonic Anhydrase IX in Cancer. Journal of Medicinal Chemistry. 67(17). 15892–15907. 3 indexed citations
2.
Schiano, Concetta, Ugo Trama, Enrico Coscioni, et al.. (2024). Epitranscriptome: A Novel Regulatory Layer during Atherosclerosis Progression. Current Medicinal Chemistry. 32(15). 2915–2930. 2 indexed citations
3.
Schiano, Concetta, Carolina Balbi, Filomena de Nigris, & Claudio Napoli. (2023). Basic Pathogenic Mechanisms and Epigenetic Players Promoted by Extracellular Vesicles in Vascular Damage. International Journal of Molecular Sciences. 24(8). 7509–7509. 6 indexed citations
4.
5.
Palinski, Wulf, Maria Monti, Rosa Camerlingo, et al.. (2021). Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients. Cell Death and Disease. 12(9). 797–797. 22 indexed citations
6.
Nigris, Filomena de, Carlo Ruosi, & Claudio Napoli. (2020). Clinical efficiency of epigenetic drugs therapy in bone malignancies. Bone. 143. 115605–115605. 31 indexed citations
7.
Nigris, Filomena de, et al.. (2020). Epigenetic therapies of osteoporosis. Bone. 142. 115680–115680. 15 indexed citations
8.
Terracciano, Daniela, Sara Terreri, Filomena de Nigris, et al.. (2017). The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1868(2). 449–455. 38 indexed citations
9.
Esposito, Carla Lucia, Silvia Nuzzo, Silvia Catuogno, et al.. (2017). STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma. Molecular Therapy — Nucleic Acids. 10. 398–411. 81 indexed citations
10.
Terreri, Sara, Vincenza Colonna, Alessandra Romanelli, et al.. (2016). New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer. Genes. 7(12). 127–127. 23 indexed citations
11.
Infante, Teresa, Francesco Paolo Mancini, Alessandro Lanza, et al.. (2015). Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(5). 975–986. 18 indexed citations
13.
Nigris, Filomena de, Raffaele Rossiello, Concetta Schiano, et al.. (2008). Deletion of Yin Yang 1 Protein in Osteosarcoma Cells on Cell Invasion and CXCR4/Angiogenesis and Metastasis. Cancer Research. 68(6). 1797–1808. 68 indexed citations
14.
Nigris, Filomena de, Monica Rienzo, Concetta Schiano, et al.. (2008). Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart. European Journal of Cancer. 44(3). 334–340. 52 indexed citations
15.
Nigris, Filomena de, Chiara Botti, Raffaele Rossiello, et al.. (2006). Cooperation between Myc and YY1 provides novel silencing transcriptional targets of α3β1-integrin in tumour cells. Oncogene. 26(3). 382–394. 39 indexed citations
16.
Napoli, Claudio, Inés Martín-Padura, Filomena de Nigris, et al.. (2003). Deletion of the p66 Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proceedings of the National Academy of Sciences. 100(4). 2112–2116. 314 indexed citations
17.
George, Sarah J., et al.. (2003). Gene therapy for vascular diseases. Bristol Research (University of Bristol). 7. 135–151. 1 indexed citations
18.
Napoli, Claudio, Lilach O. Lerman, Filomena de Nigris, Joseph Loscalzo, & Louis J. Ignarro. (2002). Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells. Journal of the American College of Cardiology. 40(8). 1515–1522. 36 indexed citations
19.
Nigris, Filomena de, Roberta Visconti, Janete M. Cerutti, et al.. (1998). Overexpression of the HIP gene coding for a heparin/heparan sulfate-binding protein in human thyroid carcinomas.. PubMed. 58(20). 4745–51. 21 indexed citations
20.
Visconti, Roberta, Janete M. Cerutti, Sabrina Battista, et al.. (1997). Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression. Oncogene. 15(16). 1987–1994. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026